Nottingham, United Kingdom, March 30, 2012 --(PR.com
)-- Chrysalis Health & Beauty announced today that they will start the sales and distribution of the recently EU novel food approved vitamin K2 as menaquinone-7 under the trade name K2VITAL™ from Norway based Kappa Biosciences.
The Novel Food application was submitted to the German Food Safety Agency by Kappa Bioscience and based on a positive German assessment, all the EU member states have acknowledged the novel food recommendation.
The K2VITAL™ product range will be sold into all European markets for food supplements, fortified foods and food products for specific nutritional purposes.
"This is a major achievement for all users of vitamin K2," said CEO Egil Greve of Kappa Bioscience. "Our products represent a technological break-through in the vitamin sector and provide the market with vitamin K2 of the highest possible purity and functionality - for use in tablets, capsules and fortification of food products. This now allows food and supplement manufactures to take vitamin K2 from a previous niche application into mainstream application due to a better cost-in-use proposition," he added.
Chrysalis Health & Beauty will be UK distributors for the new raw material range.
About Vitamin K2:
Vitamin K is a group of fat soluble vitamins known to be critical in blood coagulation. Vitamin K is divided into K1 (clotting activity) and vitamin K2, which also has extra hepatic activities. Vitamin K2 as menaquinon-7 (MK-7) has the highest bioavailability and has proven effects on bone health (EFSA 13.1 Claim) and cardiovascular health. Vitamin K2 acts as co-factor for proteins involved in calcium metabolism.
K2VITAL™ is Kappa Bioscience’s commercial product range containing pure, all-trans menaquinone-7 (MK-7). It is available in powder, granular and liquid form, each in various concentrations. K2VITAL™ is the most bio-available and cost effective form of vitamin K2 available for food and supplementation. This key nutrient offers significant health benefits for humans.
About Kappa Bioscience:
Kappa Bioscience is the innovative leader and first mover within high purity, all-trans vitamin K2 as menaquinone-7 (MK-7). Kappa Bioscience is a Norwegian based entity with substantial resources and knowledge about vitamins and vitamin K2 in particular. Kappa Bioscience is currently the only vendor with vitamin K2 as pure MK-7 in various formulations, following a traditional vitamin production process with proprietary and innovative new steps. For further information, visit http://www.kappabio.com